January
19, 2007
Blood
Cell Infusions Helpful in MNGIE
Infusions of either mature blood
cell fragments (platelets) or blood
stem cells from healthy donors partially
corrected biochemical abnormalities
in three out of four patients with
the mitochondrial disease MNGIE.
In this disease, mutations in the
gene for the thymidine phosphorylase
(TP) enzyme severely reduce its
ability to metabolize thymidine and
deoxyuridine, which accumulate to
toxic levels and damage mitochondria,
the energy-producing units of cells.
MDA grantee Michio Hirano at Columbia
University in New York was involved
in both studies, results of which
were published Oct. 24 in Neurology.
The researchers reasoned that supplying
patients with TP-producing blood cells
from donors might normalize the chemical
environment and reduce damage to mitochondria.
They infused (introduced through
a blood vessel) mature, TP-producing
platelets into a 23-year-old woman
and a 16-year-old boy with MNGIE.
In both cases, the infusions briefly
increased TP levels and reduced levels
of thymidine and deoxyuridine, although
the patients’ symptoms didn’t
improve.
The infused TP apparently doesn’t
have to enter muscle cells to be effective;
it only has to be in the vicinity
to lower the potentially damaging
compounds.
They next tried infusing stem cells
from donors, with the hope that these
cells might permanently establish
themselves in the circulation (engraft)
and continuously produce TP.
When umbilical cord stem cells were
infused into a 21-year-old man with
severe MNGIE, they failed to engraft.
But when a 30-year-old woman with
MNGIE received blood stem cells from
her healthy brother, some of them
engrafted, and she experienced less
abdominal pain, better swallowing,
and decreased numbness in her hands
and feet.
The researchers note that direct
administration of stabilized TP protein
or perhaps gene therapy with the TP
gene might be more effective treatments
than cell infusions. They added that
treatment should begin as early after
diagnosis as possible, before irreversible
damage to the mitochondria occurs.
|